Sinonasal Cancer

Our otolaryngologists, radiation oncologists, and neurosurgeons provide personalized, evidence-based care for people with any type of sinonasal cancer. We use minimally invasive surgical approaches whenever possible, and lead innovative clinical trials that may be an option for you. Throughout treatment and recovery, you have access to psychologists, social workers, and integrative medicine specialists to ensure that you receive the support you need.

Clinical Trials and Research Studies

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad

Learn More

Phase 1

A Phase 1 First-in-Human Open Label Dose Escalation Study of MGD009 A Humanized B7-H3 x CD3 Dual-Affinity Re-Targeting (DART ) Protein in Patients with Unresectable or Metastatic B7-H3-Expressing Neoplasms and Neoplasms whose Vasculature Expresses

Learn More

Phase 3

A Phase III Randomized Double-Blind Clinical Trial of Pembrolizumab (MK-3475) plus Chemotherapy (XP or FP) versus Placebo plus Chemotherapy (XP or FP) as Neoadjuvant/Adjuvant Treatment for Subjects with Gastric ad Gastroesophageal Junction (GEJ) Adenocarcinoma (KEYNOTE-585)

Learn More